Leveraging Large-scale Multi-omics Evidences to Identify Therapeutic Targets from Genome-wide Association Studies

Overview

Journal BMC Genomics

Publisher Biomed Central

Specialty Genetics

Date 2024 Nov 20

PMID 39563277

Authors

Samuel Lessard

Michael Chao

Kadri Reis

Mathieu Beauvais

Deepak K Rajpal

Jennifer Sloane

Priit Palta

Katherine Klinger

Emanuele de Rinaldis

Khader Shameer

Clement Chatelain

Affiliations

Soon will be listed here.

Abstract

Background: Therapeutic targets supported by genetic evidence from genome-wide association studies (GWAS) show higher probability of success in clinical trials. GWAS is a powerful approach to identify links between genetic variants and phenotypic variation; however, identifying the genes driving associations identified in GWAS remains challenging. Integration of molecular quantitative trait loci (molQTL) such as expression QTL (eQTL) using mendelian randomization (MR) and colocalization analyses can help with the identification of causal genes. Careful interpretation remains warranted because eQTL can affect the expression of multiple genes within the same locus.

Methods: We used a combination of genomic features that include variant annotation, activity-by-contact maps, MR, and colocalization with molQTL to prioritize causal genes across 4,611 disease GWAS and meta-analyses from biobank studies, namely FinnGen, Estonian Biobank and UK Biobank.

Results: Genes identified using this approach are enriched for gold standard causal genes and capture known biological links between disease genetics and biology. In addition, we find that eQTL colocalizing with GWAS are statistically enriched for corresponding disease-relevant tissues. We show that predicted directionality from MR is generally consistent with matched drug mechanism of actions (> 85% for approved drugs). Compared to the nearest gene mapping method, genes supported by multi-omics evidences displayed higher enrichment in approved therapeutic targets (risk ratio 1.75 vs. 2.58 for genes with the highest level of support). Finally, using this approach, we detected anassociation between the IL6 receptor signal transduction gene IL6ST and polymyalgia rheumatica, an indication for which sarilumab, a monoclonal antibody against IL-6, has been recently approved.

Conclusions: Combining variant annotation, activity-by-contact maps, and molQTL increases performance to identify causal genes, while informing on directionality which can be translated to successful target identification and drug development.

Citing Articles

Multi-ancestry Genome-Wide Association Meta-Analysis Identifies Novel Loci in Atopic Dermatitis.

Oliva M, Sarkar M, March M, Saeidian A, Mentch F, Hsieh C medRxiv. 2024; .

PMID: 38946956 PMC: 11213042. DOI: 10.1101/2024.06.17.24308897.

References

Liu J, van Sommeren S, Huang H, Ng S, Alberts R, Takahashi A . Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015; 47(9):979-986. PMC: 4881818. DOI: 10.1038/ng.3359. View

Maurano M, Humbert R, Rynes E, Thurman R, Haugen E, Wang H . Systematic localization of common disease-associated variation in regulatory DNA. Science. 2012; 337(6099):1190-5. PMC: 3771521. DOI: 10.1126/science.1222794. View

Vosa U, Claringbould A, Westra H, Bonder M, Deelen P, Zeng B . Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet. 2021; 53(9):1300-1310. PMC: 8432599. DOI: 10.1038/s41588-021-00913-z. View

Chen L, Ge B, Casale F, Vasquez L, Kwan T, Garrido-Martin D . Genetic Drivers of Epigenetic and Transcriptional Variation in Human Immune Cells. Cell. 2016; 167(5):1398-1414.e24. PMC: 5119954. DOI: 10.1016/j.cell.2016.10.026. View

Zhu Z, Zhang F, Hu H, Bakshi A, Robinson M, Powell J . Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet. 2016; 48(5):481-7. DOI: 10.1038/ng.3538. View

Leitsalu L, Haller T, Esko T, Tammesoo M, Alavere H, Snieder H . Cohort Profile: Estonian Biobank of the Estonian Genome Center, University of Tartu. Int J Epidemiol. 2014; 44(4):1137-47. DOI: 10.1093/ije/dyt268. View

Schmiedel B, Singh D, Madrigal A, Valdovino-Gonzalez A, White B, Zapardiel-Gonzalo J . Impact of Genetic Polymorphisms on Human Immune Cell Gene Expression. Cell. 2018; 175(6):1701-1715.e16. PMC: 6289654. DOI: 10.1016/j.cell.2018.10.022. View

Visscher P, Wray N, Zhang Q, Sklar P, McCarthy M, Brown M . 10 Years of GWAS Discovery: Biology, Function, and Translation. Am J Hum Genet. 2017; 101(1):5-22. PMC: 5501872. DOI: 10.1016/j.ajhg.2017.06.005. View

Schwartzentruber J, Foskolou S, Kilpinen H, Rodrigues J, Alasoo K, Knights A . Molecular and functional variation in iPSC-derived sensory neurons. Nat Genet. 2017; 50(1):54-61. PMC: 5742539. DOI: 10.1038/s41588-017-0005-8. View

10.

Kilpinen H, Goncalves A, Leha A, Afzal V, Alasoo K, Ashford S . Common genetic variation drives molecular heterogeneity in human iPSCs. Nature. 2017; 546(7658):370-375. PMC: 5524171. DOI: 10.1038/nature22403. View

11.

Ghoussaini M, Mountjoy E, Carmona M, Peat G, Schmidt E, Hercules A . Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics. Nucleic Acids Res. 2020; 49(D1):D1311-D1320. PMC: 7778936. DOI: 10.1093/nar/gkaa840. View

12.

Ng B, White C, Klein H, Sieberts S, McCabe C, Patrick E . An xQTL map integrates the genetic architecture of the human brain's transcriptome and epigenome. Nat Neurosci. 2017; 20(10):1418-1426. PMC: 5785926. DOI: 10.1038/nn.4632. View

13.

King E, Davis J, Degner J . Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval. PLoS Genet. 2019; 15(12):e1008489. PMC: 6907751. DOI: 10.1371/journal.pgen.1008489. View

14.

Feder J, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy D, Basava A . A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996; 13(4):399-408. DOI: 10.1038/ng0896-399. View

15.

Buil A, Brown A, Lappalainen T, Vinuela A, Davies M, Zheng H . Gene-gene and gene-environment interactions detected by transcriptome sequence analysis in twins. Nat Genet. 2014; 47(1):88-91. PMC: 4643454. DOI: 10.1038/ng.3162. View

16.

Theusch E, Chen Y, Rotter J, Krauss R, Medina M . Genetic variants modulate gene expression statin response in human lymphoblastoid cell lines. BMC Genomics. 2020; 21(1):555. PMC: 7430882. DOI: 10.1186/s12864-020-06966-4. View

17.

Browning S, Browning B . Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. Am J Hum Genet. 2007; 81(5):1084-97. PMC: 2265661. DOI: 10.1086/521987. View

18.

Pashos E, Park Y, Wang X, Raghavan A, Yang W, Abbey D . Large, Diverse Population Cohorts of hiPSCs and Derived Hepatocyte-like Cells Reveal Functional Genetic Variation at Blood Lipid-Associated Loci. Cell Stem Cell. 2017; 20(4):558-570.e10. PMC: 5476422. DOI: 10.1016/j.stem.2017.03.017. View

19.

Zhu A, Matoba N, Wilson E, Tapia A, Li Y, Ibrahim J . MRLocus: Identifying causal genes mediating a trait through Bayesian estimation of allelic heterogeneity. PLoS Genet. 2021; 17(4):e1009455. PMC: 8084342. DOI: 10.1371/journal.pgen.1009455. View

20.

Feagan B, Sandborn W, Gasink C, Jacobstein D, Lang Y, Friedman J . Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease. N Engl J Med. 2016; 375(20):1946-1960. DOI: 10.1056/NEJMoa1602773. View